Alpinetin is a novel plant
flavonoid derived from Alpinia katsumadai Hayata, found to possess strong anticancer effects. However, the antitumor effect of
alpinetin on
pancreatic cancer cells and the detailed mechanism remain unclear. The aim of this study was to investigate
alpinetin's beneficial effect on
pancreatic cancer and the possible molecular mechanism involved.
Pancreatic cancer cell lines were treated with
alpinetin at various doses and for different times, and the effect of
alpinetin on cell growth inhibition, apoptosis and the cell cycle was determined. The expression of Bcl-2, Bcl-xL, XIAP and Bax, the activity of
caspases and the levels of cytochrome c released were measured. The results showed that
alpinetin inhibited the viability of three
pancreatic cancer cell lines and induced apoptosis of BxPC-3 cells in a dose- and time-dependent manner. This was accompanied by regulation of the expression of Bcl-2, Bcl-xL, Bax and XIAP. Furthermore,
alpinetin treatment led to the release of cytochrome c and activation of caspases-3, -8 and -9
proteins. Taken together, our studies indicate that
alpinetin inhibited the proliferation of
pancreatic cancer cells possibly through the regulation of the Bcl-2 family and XIAP expression, release of cytochrome c and the activation of
caspases.
Alpinetin may serve as a potential agent for the development of
pancreatic cancer cell
therapies.